chr10-69404881-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000373306.5(TACR2):āc.1142G>Cā(p.Gly381Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000054 in 1,611,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000373306.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TACR2 | NM_001057.3 | c.1142G>C | p.Gly381Ala | missense_variant | 5/5 | ENST00000373306.5 | NP_001048.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TACR2 | ENST00000373306.5 | c.1142G>C | p.Gly381Ala | missense_variant | 5/5 | 1 | NM_001057.3 | ENSP00000362403.4 | ||
TACR2 | ENST00000373307.5 | c.506G>C | p.Gly169Ala | missense_variant | 3/3 | 2 | ENSP00000362404.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000814 AC: 20AN: 245730Hom.: 0 AF XY: 0.000105 AC XY: 14AN XY: 133038
GnomAD4 exome AF: 0.0000548 AC: 80AN: 1459320Hom.: 0 Cov.: 30 AF XY: 0.0000675 AC XY: 49AN XY: 725798
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.1142G>C (p.G381A) alteration is located in exon 5 (coding exon 5) of the TACR2 gene. This alteration results from a G to C substitution at nucleotide position 1142, causing the glycine (G) at amino acid position 381 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at